source
- Amgen stands by rare disease drug Tavneos amid Japan liver toxicity reportThe FDA wants it off the market. European regulators are investigating data-integrity concerns. And now, a pharma company selling the drug in Japan is warning doctors against writing new prescripti…Endpoints · 2mo ago↗ source
- FDA's unreleased Covid vaccine deaths report is published by lawmakerAn analysis launched by former FDA leaders to look into claims of pediatric deaths related to Covid-19 vaccines was published by a Republican lawmaker, months after the agency's self-imposed deadli…Endpoints · 2mo ago↗ source
- Regeneron reaches $125M Parabilis deal for hard-to-catch drug targetsAs Regeneron’s cancer portfolio continues to suffer setbacks, the company is placing a bet in a different direction through a deal with Parabilis Medicines valued at as much as $2.2 billion. Parabi…